2026 Shanghai CPHI Wraps Up, Our Empty Capsules Are Well Received by Overseas Clients

The much-anticipated 2026 CPHI China Shanghai has successfully concluded. As one of the most influential professional exhibitions covering the whole pharmaceutical industrial chain, this event gathered thousands of domestic and foreign suppliers of pharmaceutical raw materials and excipients, attracting global purchasers, pharmaceutical manufacturers and health supplement producers to visit and negotiate.
We brought our full-series empty capsules to this exhibition, including gelatin empty capsules, HPMC plant-based capsules, enteric-coated capsules and zinc oxide capsules, covering all sizes from 000# to 4#. On-site, we displayed photos of standardized production workshops, our production lines with an annual output of 70 billion capsules, as well as full sets of pharmaceutical regulatory certifications, to intuitively present our core advantages of large-scale production and strict quality control as an original manufacturer.
During the exhibition, our booth welcomed buyers from Southeast Asia, Central Asia, the Middle East, Europe, America and other regions. Our foreign trade team introduced product features, delivery cycles and one-stop customs clearance service for export one-on-one, and provided customized capsule solutions for clients’ different demands of health supplements, traditional Chinese medicine and chemical preparations. Many clients took samples for testing on site and reached intentions of long-term supply, with multiple trial orders confirmed.
With over 50 years of experience in capsule production, we stick to compliant manufacturing and hold complete import & export qualifications to supply stable products for global markets. This CPHI trip not only introduced our premium empty capsules to more overseas partners, but also connected us with upstream and downstream industry resources, laying a solid foundation for further global market expansion and long-term international cooperation.
We will keep optimizing production technology, upgrading capacity and quality standards, and supply stable, cost-effective medicinal empty capsules to pharmaceutical enterprises worldwide via international professional exhibitions in the future.